<?xml version="1.0" ?>
<document id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9">
  <chunk id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c0" text="Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 Strains">
    <entity charOffset="29-61" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c0.e0" ontology_id="CHEBI_53756" text="Reverse Transcriptase Inhibitors" type="chemical"/>
    <entity charOffset="37-61" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c0.e1" ontology_id="CHEBI_37416" text="Transcriptase Inhibitors" type="chemical"/>
    <entity charOffset="51-61" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c0.e2" ontology_id="CHEBI_35222" text="Inhibitors" type="chemical"/>
    <entity charOffset="74-77" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c0.e3" ontology_id="CHEBI_10110" text="AZT" type="chemical"/>
  </chunk>
  <chunk id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1" text="Reverse transcriptase inhibitors (RTIs), including nucleoside RTIs (NRTIs) and non-nucleoside RTIs (NNRTIs), are critical antiretroviral drugs for the treatment of human immunodeficiency virus (HIV) infection. Emergence of multi-RTI resistance calls for the development of more potent therapeutics or regimens against RTI-resistant strains. Here, we demonstrated that combining azidothymidine (AZT) with a new NNRTIs under development, diarylpyridine (DAPA)-2e, diarylanilin (DAAN)-14h, or DAAN-15h, resulted in strong synergism against infection by divergent HIV-1 strains, including those resistant to NRTIs and NNRTIs, suggesting the potential for developing these novel NNRTIs as salvage therapy for HIV/acquired immune deficiency syndrome (AIDS) patients.">
    <entity charOffset="0-32" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e0" ontology_id="CHEBI_53756" text="Reverse transcriptase inhibitors" type="chemical"/>
    <entity charOffset="8-32" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e1" ontology_id="CHEBI_37416" text="transcriptase inhibitors" type="chemical"/>
    <entity charOffset="22-32" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e2" ontology_id="CHEBI_35222" text="inhibitors" type="chemical"/>
    <entity charOffset="51-61" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e3" ontology_id="CHEBI_33838" text="nucleoside" type="chemical"/>
    <entity charOffset="137-142" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e4" ontology_id="CHEBI_23888" text="drugs" type="chemical"/>
    <entity charOffset="378-392" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e5" ontology_id="CHEBI_10110" text="azidothymidine" type="chemical"/>
    <entity charOffset="394-397" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e6" ontology_id="CHEBI_10110" text="AZT" type="chemical"/>
    <entity charOffset="735-743" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e7" ontology_id="DOID_225" text="syndrome" type="disease"/>
    <entity charOffset="745-749" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e8" ontology_id="DOID_635" text="AIDS" type="disease"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e0" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e7" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p0" relation="true"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e0" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e8" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p1" relation="true"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e1" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e7" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p2" relation="true"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e1" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e8" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p3" relation="true"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e2" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e7" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p4" relation="true"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e2" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e8" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p5" relation="true"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e3" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e7" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p6" relation="true"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e3" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e8" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p7" relation="true"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e4" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e7" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p8" relation="true"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e4" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e8" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p9" relation="true"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e5" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e7" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p10" relation="true"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e5" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e8" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p11" relation="true"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e6" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e7" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p12" relation="true"/>
    <pair e1="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e6" e2="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.e8" id="e37ede300a3a671cb392f6a06e5b5e0af6e34fd9.c1.p13" relation="true"/>
  </chunk>
</document>
